The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStm Grp. Regulatory News (STM)

Share Price Information for Stm Grp. (STM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.50
Bid: 55.00
Ask: 60.00
Change: 0.00 (0.00%)
Spread: 5.00 (9.091%)
Open: 57.50
High: 57.50
Low: 57.50
Prev. Close: 57.50
STM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - STM Group plc

25 Jul 2023 07:00

RNS Number : 0301H
STM Group PLC
25 July 2023
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

STM Group Plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

STM Group Plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

24 July 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Ordinary shares of 0.1 pence each:

 

Person

Role

No. of ordinary shares

Percentage holding

 

Alan Kentish

 

Clifton Participations Inc (the shares form part of the assets of the Perros Trust, of which the settlor is Alan Kentish, the independent trustee is Lesley Nuttall and the potential beneficiaries are Alan Kentish, his wife Louise Kentish and their immediate family)

Chief Executive Officer

 

866,667

 

5,552,150

 

 

 

 

 

 

 

Total 6,418,817

 

1.46%

 

9.35%

 

 

 

 

 

 

 

Total 10.80%

Therese Neish

Interim Chief Financial Officer

492,756

0.83%

 

No share options or incentive awards are in place for any person acting in concert with the Company including Executive Directors and Non-Executive Directors.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

24 July 2023

Contact name:

Alan Kentish, Chief Executive Officer

Telephone number:

+34 610 708 758

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEENKQBKDBKBKOB
Date   Source Headline
4th Apr 20247:00 amRNSUpdate on the Acquisition
23rd Feb 20247:00 amRNSTrading Update & Acquisition Update
22nd Dec 20238:56 amRNSForm 8.3 - STM GROUP PLC
6th Dec 202312:27 pmRNSResults of Court Meeting and EGM
27th Nov 20233:30 pmPRNForm 8.3 - STM Group Plc
7th Nov 20237:00 amRNSPublication of Scheme Document
30th Oct 20231:20 pmRNSForm 8.5 (EPT/NON-RI)
24th Oct 20233:35 pmRNSForm 8.5 (EPT/NON-RI)
24th Oct 202312:02 pmRNSForm 8.5 (EPT/NON-RI)
23rd Oct 202310:01 amRNSForm 8.5 (EPT/NON-RI)
10th Oct 20237:00 amRNSOffer by Jambo SRC Limited
3rd Oct 202311:01 amRNSForm 8.5 (EPT/NON-RI) - STM Group PLC
28th Sep 20237:00 amRNSInterim Results
27th Sep 20234:48 pmRNSOffer Update and PUSU Extension
25th Sep 20237:00 amRNSBoard Update
15th Sep 20234:41 pmRNSIrrevocable undertakings and letter of intent
8th Sep 20237:00 amRNSPUSU extension and irrevocable undertakings
5th Sep 20234:53 pmRNSOffer update
22nd Aug 20231:04 pmRNSResult of AGM
22nd Aug 20238:04 amRNSOffer update - further extension to PUSU Deadline
8th Aug 20237:00 amRNSOffer update - extension to PUSU Deadline
28th Jul 20232:23 pmRNSForm 8.3 - Arron Banks - STM Group plc (2)
28th Jul 20232:17 pmRNSForm 8.3 - Arron Banks - STM Group plc (1)
27th Jul 20235:29 pmRNSForm 8.3 - Sacisa Ltd - STM Group plc
27th Jul 20235:13 pmRNSForm 8 (OPD) - Replacement - STM Group plc
26th Jul 20235:47 pmRNSForm 8.3 - Brian Geary - STM Group plc
25th Jul 20235:55 pmRNSForm 8.3 - STM Group plc
25th Jul 20232:26 pmRNSForm 8.3 - Septer Limited (Replacement)
25th Jul 20231:39 pmRNSForm 8.3 - STM Group Employee Trust
25th Jul 20237:00 amRNSForm 8 (OPD) - STM Group plc
24th Jul 20235:30 pmRNSForm 8.3 - STM Group plc
24th Jul 202311:40 amRNSForm 8.3 - STM Group plc
24th Jul 202310:29 amRNSForm 8.3 - STM Group Plc
21st Jul 20236:03 pmRNSForm 8.3 - Eastmount Capital (Replacement)
21st Jul 20232:12 pmRNSForm 8.3 - STM Group PLC
21st Jul 20237:00 amRNSForm 8.3 - Eastmount Capital - STM Group plc
20th Jul 202310:29 amRNSForm 8 (OPD) STM Group plc
19th Jul 20235:35 pmRNSForm 8.3 - STM Group PLC
19th Jul 202311:23 amRNSForm 8.3 - Quest Traders - STM Group plc
13th Jul 20237:54 amRNSForm 8 (DD) - STM GROUP PLC
12th Jul 20237:00 amRNSConfirmation of AGM details
11th Jul 20235:11 pmRNSForm 8.3 - STM Group Plc
11th Jul 20231:29 pmPRNForm 8.3 - STM Group Plc
11th Jul 202311:55 amRNSForm 8.3 - STM Group PLC
11th Jul 20237:00 amRNSStatement Regarding Possible Cash Offer
30th Jun 20237:00 amRNSNotice of AGM
27th Jun 20237:00 amRNSFinal Results
30th May 20237:00 amRNSClient Interest Policy and Trading Update
25th May 20237:00 amRNSUpdate re 2021 life assurance audits
4th May 20237:00 amRNSUpdate re Results and Directorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.